Background: Hepatic encephalopathy (HE) in patients with chronic liver disease (CLD) is one of the main causes of reentry to the emergency department. Oxidative stress (OxS) regulated by ammonia leads to cerebral edema and astrocytes senescence in animal models, but seems to be different in humans. Objective: To analyze if OxS and ammonia in plasma are related to each other in the different grades of HE-CLD and to compare them with healthy volunteers (HV). Methods: In a cross-sectional study, we included 60 subjects in 2 groups: (a) 30 HV and (b) 30 HE patients. Plasma levels of oxidation lipids/proteins, ammonia, and West-Haven score were evaluated. Student t test, Spearman’s correlation, and ANOVA with Dunn’s post hoc test were performed. Results: Ammonia in HV and HE patients was 39–49 vs. 95–345 μmol/L, respectively (p < 0.0001). Malondialdehyde (MDA) in HV was 6.58 ± 3.11 compared to 16.69 ± 6.19 μmol/L in HE (p < 0.0001). Protein oxidation by osazone (carbonyls), formazan, and dityrosines was higher in HE than in HV (p < 0.0001). Ammonia level was directly associated to HE severity, but without correlation with lipid MDA or protein OxS formazan, carbonyls, and dityrosines. Lipid peroxidation showed higher levels at degree 2 and protein oxidation at degree 3 of HE. Conclusions: We confirm that OxS accompanies hyperammonemia in HE; however they contribute in different proportions to their natural progression. Early reduction of OxS in HE could contribute to minimize the neurotoxicity into CLD.

Keywords:
Lipid peroxidation, Protein oxidation, Ammonia, Chronic liver disease, Hepatic encephalopathy
1.
Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia.
Metab Brain Dis
. 2002 Dec;17(4):221–7.
2.
Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects.
Hepat Med
. 2018 Mar;10:1–11.
3.
Heidari R, Jamshidzadeh A, Ghanbarinejad V, Ommati MM, Niknahad H. Taurine supplementation abates cirrhosis-associated locomotor dysfunction.
Clin Exp Hepatol
. 2018 Jun;4(2):72–82.
4.
McCord JM. The evolution of free radicals and oxidative stress.
Am J Med
. 2000 Jun;108(8):652–9.
5.
Sies H. Oxidative stress: a concept in redox biology and medicine.
Redox Biol
. 2015;4:180–3.
6.
Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions.
Annu Rev Biochem
. 1993;62(1):797–821.
7.
Skowrońska M, Albrecht J. Oxidative and nitrosative stress in ammonia neurotoxicity.
Neurochem Int
. 2013 Apr;62(5):731–7.
8.
Murthy CR, Rama Rao KV, Bai G, Norenberg MD. Ammonia-induced production of free radicals in primary cultures of rat astrocytes.
J Neurosci Res
. 2001 Oct;66(2):282–8.
9.
Bosoi CR, Tremblay M, Rose CF. Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats.
Liver Int
. 2014 Oct;34(9):1322–9.
10.
Görg B, Karababa A, Häussinger D. Hepatic Encephalopathy and Astrocyte Senescence.
J Clin Exp Hepatol
. 2018 Sep;8(3):294–300.
11.
Aksoy H, Koruk M, Akçay F. The Relationship Between Serum Malondialdehyde and Ceruloplasmin in Chronic Liver Disease.
Turk J Biochem.
2003;28(2):32–4.
12.
Ferenci P. Hepatic encephalopathy.
Gastroenterol Rep (Oxf)
. 2017 May;5(2):138–47.
13.
American Association for the Study of Liver DiseasesEuropean Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases.
J Hepatol
. 2014 Sep;61(3):642–59.
14.
Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma.
Methods Mol Biol
. 1998;108:107–10.
15.
Gieseg SP, Simpson JA, Charlton TS, Duncan MW, Dean RT. Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins.
Biochemistry
. 1993 May;32(18):4780–6.
16.
Heinecke JW, Li W, Daehnke HL 3rd, Goldstein JA. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages.
J Biol Chem
. 1993 Feb;268(6):4069–77.
17.
Malencik DA, Sprouse JF, Swanson CA, Anderson SR. Dityrosine: preparation, isolation, and analysis.
Anal Biochem
. 1996 Nov;242(2):202–13.
18.
Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay.
Methods Enzymol
. 1994;233:357–63.
19.
Montes-Cortes DH, Hicks JJ, Ceballos-Reyes GM, Garcia-Sanchez JR, Medina-Navarro R, Olivares-Corichi IM. Chemical and functional changes of human insulin by in vitro incubation with blood from diabetic patients in oxidative stress.
Metabolism
. 2010 Jul;59(7):935–42.
20.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent.
J Biol Chem
. 1951 Nov;193(1):265–75.
21.
Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.
Metab Brain Dis
. 2013 Jun;28(2):175–8.
22.
Ge PS, Runyon BA. Serum ammonia level for the evaluation of hepatic encephalopathy.
JAMA
. 2014 Aug;312(6):643–4.
23.
Romero-Gómez M, Ramos-Guerrero R, Grande L, de Terán LC, Corpas R, Camacho I, et al. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.
J Hepatol
. 2004 Jul;41(1):49–54.
24.
Mans AM, DeJoseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure.
J Neurochem
. 1994 Nov;63(5):1829–38.
25.
Vince AJ, Burridge SM. Ammonia production by intestinal bacteria: the effects of lactose, lactulose and glucose.
J Med Microbiol
. 1980 May;13(2):177–91.
26.
LeVeen HH, LeVeen EG, LeVeen RF. Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy.
Biomed Pharmacother
. 1994;48(3-4):157–66.
27.
Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy.
Gastroenterol Hepatol (N Y)
. 2011 Apr;7(4):222–33.
28.
Koruk M, Aksoy H, Akçay F, Onuk MD. Antioxidant capacity and nitric oxide in patients with hepatic cirrhosis.
Ann Clin Lab Sci
. 2002;32(3):252–6.
29.
Jones RM, Neish AS. Redox signaling mediated by the gut microbiota.
Free Radic Biol Med
. 2017 Apr;105:41–7.
30.
Kountouras J, Boziki M, Polyzos SA, Katsinelos P, Gavalas E, Zeglinas C, et al. Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.
Free Radic Res
. 2017 Jan;51(1):73–9.
31.
Tsukamoto H, Rippe R, Niemelä O, Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis.
J Gastroenterol Hepatol
. 1995;10(Suppl 1):S50–3.
32.
Viveiros A, Finkenstedt A, Schaefer B, Mandorfer M, Scheiner B, Lehner K, et al. Transferrin as a predictor of survival in cirrhosis.
Liver Transpl
. 2018 Mar;24(3):343–51.
33.
Comporti M, Arezzini B, Signorini C, Vecchio D, Gardi C. Oxidative stress, isoprostanes and hepatic fibrosis.
Histol Histopathol
. 2009 Jul;24(7):893–900.
34.
Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.
Oxid Med Cell Longev
. 2014;2014:360438.
35.
Sathyasaikumar KV, Swapna I, Reddy PV, Murthy CR, Dutta Gupta A, Senthilkumaran B, et al. Fulminant hepatic failure in rats induces oxidative stress differentially in cerebral cortex, cerebellum and pons medulla.
Neurochem Res
. 2007 Mar;32(3):517–24.
36.
Dhanda S, Sunkaria A, Halder A, Sandhir R. Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.
Metab Brain Dis
. 2018 Feb;33(1):209–23.
37.
Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis.
Free Radic Biol Med
. 1996;20(3):351–9.
38.
Brunk UT. On the origin of lipofuscin; the iron content of residual bodies, and the relation of these organelles to the lysosomal vacuome. A study on cultured human glial cells.
Adv Exp Med Biol
. 1989;266:313–20.
39.
Giménez-Garzó C, Urios A, Agustí A, Mangas-Losada A, García-García R, Escudero-García D, et al. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment.
Free Radic Res
. 2018 Jan;52(1):118–33.
40.
Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress.
Clin Chim Acta
. 2003 Mar;329(1-2):23–38.
41.
Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, Sonaka I, et al. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions.
FEBS J
. 2006 Jul;273(14):3346–57.
42.
Otagiri M, Chuang VT. Pharmaceutically important pre- and posttranslational modifications on human serum albumin.
Biol Pharm Bull
. 2009 Apr;32(4):527–34.
43.
Gonzàlez-Quintela A, Alende MR, Gamallo R, Gonzàlez-Gil P, López-Ben S, Tomé S, et al. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease.
Hepatogastroenterology
. 2003 Nov-Dec;50(54):2121–6.
44.
Gupta A, Wani A, Joshi A, Ahsan H, Ahmad R. Characterization of human serum immunoglobulin g modified with singlet oxygen.
Indian J Clin Biochem
. 2014 Jan;29(1):63–8.
45.
Rasheed Z. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies.
Clin Biochem
. 2008 Jun;41(9):663–9.
46.
Uesugi M, Yoshida K, Jasin HE. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite.
J Immunol
. 2000 Dec;165(11):6532–7.
47.
Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance.
Science
. 1987 Feb;235(4792):1043–6.
48.
Witting PK, Westerlund C, Stocker R. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids.
J Lipid Res
. 1996 Apr;37(4):853–67.
49.
Kaur H, Hughes MN, Green CJ, Naughton P, Foresti R, Motterlini R. Interaction of bilirubin and biliverdin with reactive nitrogen species.
FEBS Lett
. 2003 May;543(1-3):113–9.
50.
Krones E, Wagner M, Eller K, Rosenkranz AR, Trauner M, Fickert P. Bile acid-induced cholemic nephropathy.
Dig Dis
. 2015;33(3):367–75.
51.
Büyükaşık NŞ, Büyükaşık Y. Chronic liver diseases and iron: a concise review with emphasis on hypotransferrinemia and hypohepcidinemia.
Turk J Med Sci
. 2016 Nov;46(5):1281–91.
52.
Puppo A, Halliwell B. Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent?
Biochem J
. 1988 Jan;249(1):185–90.
53.
Butterworth RF. Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis.
Metab Brain Dis
. 2019, DOI: 10.1007/s11011-019-00463-8.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.